Treatment of mice with an IL-1β-neutralising antibody had no clear effect on primary tumor growth, but effectively inhibited CTSC-increased levels of circulating IL-6 and CCL3, as well as lung metastasis in mice. The gene discussed is IL6; the disease is neoplasm.